Australian-based regenerative medicine company Mesoblast recently announced results of the second part of an ongoing clinical trial. The research involves cell injections given to patients with chronic lower back pain related to degenerative disc disease (DDD). Initial results suggest the […]
With nearly 20,000 new spinal cord injuries occurring in the United States each year, any encouraging research involving possible treatment options is welcome news. From getting a Coflex implant to receiving spinal cord stimulation, the options have increased over time. […]
According to Los Angeles spine surgeons, for more than a quarter-century, spinal cord stimulation has been a standard treatment option for patients with chronic pain. Many patients who undergo the procedure report anywhere from a 50 to 70 percent reduction […]